AVADEL PHARMACEUTICALS PLC - Common Stock (AVDL)

Historical Holders from Q1 2023 to Q3 2025

Symbol
AVDL on Nasdaq
CUSIP
G29687103
Type / Class
Equity / Common Stock
Shares outstanding
96.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
79M
Holdings value
$1.21B
% of all portfolios
0.005%
Grand Portfolio weight change
0%
Number of holders
179
Number of buys
90
Number of sells
-77
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AVADEL PHARMACEUTICALS PLC - Common Stock (AVDL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 7.7% -31.7% $113M -$56.5M 7.43M -33.3% JANUS HENDERSON GROUP PLC Sep 30, 2025
BlackRock, Inc. 7% $63.9M 6.74M BlackRock, Inc. Jun 30, 2025
Two Seas Capital LP 6.4% +26% $91.2M $17.9M 6.16M +24.4% Two Seas Capital LP Jun 30, 2025
BRANDES INVESTMENT PARTNERS, LP 5.9% $40.4M 5.67M BRANDES INVESTMENT PARTNERS, LP Mar 31, 2025
VANGUARD GROUP INC 5.74% $52.7M 5.56M The Vanguard Group Jun 30, 2025

Institutional Holders of AVADEL PHARMACEUTICALS PLC - Common Stock (AVDL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 79M $1.21B -$19M $15.27 179
2025 Q2 80.5M $712M +$33.2M $8.85 166
2025 Q1 77M $605M -$36M $7.83 169
2024 Q4 78.7M $827M +$46.3M $10.51 153
2024 Q3 73.4M $962M +$83.1M $13.12 176
2024 Q2 66.2M $931M +$906M $14.06 143
2024 Q1 1.62M $27.4M +$27.4M $16.89 7
2023 Q2 0 $0 -$4.29K 0
2023 Q1 468 $4.29K $0 $9.16 1